Inhalable Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: I7F1896B55C2EN
Market Monitor Global

Abstracts

Inhalable drugs are medicines that inhaled directly into lungs to achieve higher curing efficiency.

This report contains market size and forecasts of Inhalable Drugs in global, including the following market information:

Global Inhalable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Inhalable Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Inhalable Drugs companies in 2021 (%)

The global Inhalable Drugs market was valued at 22460 million in 2021 and is projected to reach US$ 28420 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Suspension Aerosol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inhalable Drugs include NanoDerma, Pfizer, Aradigm Corporation, Alkerme, Dura Pharmaceuticals and AeroGen and Inhale Therapeutic Systems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhalable Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inhalable Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Inhalable Drugs Market Segment Percentages, by Type, 2021 (%)

• Suspension Aerosol
• Solution Aerosol
• Dry Powder Formulation

Global Inhalable Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Inhalable Drugs Market Segment Percentages, by Application, 2021 (%)

• Respiratory Diseases
• Non-respiratory Diseases

Global Inhalable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Inhalable Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inhalable Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Inhalable Drugs revenues share in global market, 2021 (%)

Key companies Inhalable Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Inhalable Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• NanoDerma
• Pfizer
• Aradigm Corporation
• Alkerme
• Dura Pharmaceuticals
• AeroGen and Inhale Therapeutic Systems

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inhalable Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inhalable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INHALABLE DRUGS OVERALL MARKET SIZE

2.1 Global Inhalable Drugs Market Size: 2021 VS 2028
2.2 Global Inhalable Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Inhalable Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Inhalable Drugs Players in Global Market
3.2 Top Global Inhalable Drugs Companies Ranked by Revenue
3.3 Global Inhalable Drugs Revenue by Companies
3.4 Global Inhalable Drugs Sales by Companies
3.5 Global Inhalable Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Inhalable Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Inhalable Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inhalable Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Inhalable Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Inhalable Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Inhalable Drugs Market Size Markets, 2021 & 2028
  4.1.2 Suspension Aerosol
  4.1.3 Solution Aerosol
  4.1.4 Dry Powder Formulation
4.2 By Type - Global Inhalable Drugs Revenue & Forecasts
  4.2.1 By Type - Global Inhalable Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Inhalable Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Inhalable Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Inhalable Drugs Sales & Forecasts
  4.3.1 By Type - Global Inhalable Drugs Sales, 2017-2022
  4.3.2 By Type - Global Inhalable Drugs Sales, 2023-2028
  4.3.3 By Type - Global Inhalable Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Inhalable Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inhalable Drugs Market Size, 2021 & 2028
  5.1.2 Respiratory Diseases
  5.1.3 Non-respiratory Diseases
5.2 By Application - Global Inhalable Drugs Revenue & Forecasts
  5.2.1 By Application - Global Inhalable Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Inhalable Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Inhalable Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Inhalable Drugs Sales & Forecasts
  5.3.1 By Application - Global Inhalable Drugs Sales, 2017-2022
  5.3.2 By Application - Global Inhalable Drugs Sales, 2023-2028
  5.3.3 By Application - Global Inhalable Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Inhalable Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Inhalable Drugs Market Size, 2021 & 2028
6.2 By Region - Global Inhalable Drugs Revenue & Forecasts
  6.2.1 By Region - Global Inhalable Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Inhalable Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Inhalable Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Inhalable Drugs Sales & Forecasts
  6.3.1 By Region - Global Inhalable Drugs Sales, 2017-2022
  6.3.2 By Region - Global Inhalable Drugs Sales, 2023-2028
  6.3.3 By Region - Global Inhalable Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Inhalable Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Inhalable Drugs Sales, 2017-2028
  6.4.3 US Inhalable Drugs Market Size, 2017-2028
  6.4.4 Canada Inhalable Drugs Market Size, 2017-2028
  6.4.5 Mexico Inhalable Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Inhalable Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Inhalable Drugs Sales, 2017-2028
  6.5.3 Germany Inhalable Drugs Market Size, 2017-2028
  6.5.4 France Inhalable Drugs Market Size, 2017-2028
  6.5.5 U.K. Inhalable Drugs Market Size, 2017-2028
  6.5.6 Italy Inhalable Drugs Market Size, 2017-2028
  6.5.7 Russia Inhalable Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Inhalable Drugs Market Size, 2017-2028
  6.5.9 Benelux Inhalable Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Inhalable Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Inhalable Drugs Sales, 2017-2028
  6.6.3 China Inhalable Drugs Market Size, 2017-2028
  6.6.4 Japan Inhalable Drugs Market Size, 2017-2028
  6.6.5 South Korea Inhalable Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Inhalable Drugs Market Size, 2017-2028
  6.6.7 India Inhalable Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Inhalable Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Inhalable Drugs Sales, 2017-2028
  6.7.3 Brazil Inhalable Drugs Market Size, 2017-2028
  6.7.4 Argentina Inhalable Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Inhalable Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Inhalable Drugs Sales, 2017-2028
  6.8.3 Turkey Inhalable Drugs Market Size, 2017-2028
  6.8.4 Israel Inhalable Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Inhalable Drugs Market Size, 2017-2028
  6.8.6 UAE Inhalable Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 NanoDerma
  7.1.1 NanoDerma Corporate Summary
  7.1.2 NanoDerma Business Overview
  7.1.3 NanoDerma Inhalable Drugs Major Product Offerings
  7.1.4 NanoDerma Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 NanoDerma Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Inhalable Drugs Major Product Offerings
  7.2.4 Pfizer Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 Aradigm Corporation
  7.3.1 Aradigm Corporation Corporate Summary
  7.3.2 Aradigm Corporation Business Overview
  7.3.3 Aradigm Corporation Inhalable Drugs Major Product Offerings
  7.3.4 Aradigm Corporation Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Aradigm Corporation Key News
7.4 Alkerme
  7.4.1 Alkerme Corporate Summary
  7.4.2 Alkerme Business Overview
  7.4.3 Alkerme Inhalable Drugs Major Product Offerings
  7.4.4 Alkerme Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Alkerme Key News
7.5 Dura Pharmaceuticals
  7.5.1 Dura Pharmaceuticals Corporate Summary
  7.5.2 Dura Pharmaceuticals Business Overview
  7.5.3 Dura Pharmaceuticals Inhalable Drugs Major Product Offerings
  7.5.4 Dura Pharmaceuticals Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Dura Pharmaceuticals Key News
7.6 AeroGen and Inhale Therapeutic Systems
  7.6.1 AeroGen and Inhale Therapeutic Systems Corporate Summary
  7.6.2 AeroGen and Inhale Therapeutic Systems Business Overview
  7.6.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Major Product Offerings
  7.6.4 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 AeroGen and Inhale Therapeutic Systems Key News

8 GLOBAL INHALABLE DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Inhalable Drugs Production Capacity, 2017-2028
8.2 Inhalable Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Inhalable Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 INHALABLE DRUGS SUPPLY CHAIN ANALYSIS

10.1 Inhalable Drugs Industry Value Chain
10.2 Inhalable Drugs Upstream Market
10.3 Inhalable Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Inhalable Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Inhalable Drugs in Global Market
Table 2. Top Inhalable Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Inhalable Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Inhalable Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Inhalable Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Inhalable Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Inhalable Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Inhalable Drugs Product Type
Table 9. List of Global Tier 1 Inhalable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inhalable Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Inhalable Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Inhalable Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Inhalable Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Inhalable Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Inhalable Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Inhalable Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Inhalable Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Inhalable Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Inhalable Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Inhalable Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Inhalable Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Inhalable Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Inhalable Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Inhalable Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Inhalable Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Inhalable Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Inhalable Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Inhalable Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Inhalable Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Inhalable Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Inhalable Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Inhalable Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Inhalable Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Inhalable Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Inhalable Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Inhalable Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Inhalable Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Inhalable Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Inhalable Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Inhalable Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Inhalable Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Inhalable Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Inhalable Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Inhalable Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Inhalable Drugs Sales, (K Units), 2023-2028
Table 46. NanoDerma Corporate Summary
Table 47. NanoDerma Inhalable Drugs Product Offerings
Table 48. NanoDerma Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Inhalable Drugs Product Offerings
Table 51. Pfizer Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Aradigm Corporation Corporate Summary
Table 53. Aradigm Corporation Inhalable Drugs Product Offerings
Table 54. Aradigm Corporation Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Alkerme Corporate Summary
Table 56. Alkerme Inhalable Drugs Product Offerings
Table 57. Alkerme Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Dura Pharmaceuticals Corporate Summary
Table 59. Dura Pharmaceuticals Inhalable Drugs Product Offerings
Table 60. Dura Pharmaceuticals Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. AeroGen and Inhale Therapeutic Systems Corporate Summary
Table 62. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product Offerings
Table 63. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Inhalable Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Inhalable Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Inhalable Drugs Production by Region, 2017-2022 (K Units)
Table 67. Global Inhalable Drugs Production by Region, 2023-2028 (K Units)
Table 68. Inhalable Drugs Market Opportunities & Trends in Global Market
Table 69. Inhalable Drugs Market Drivers in Global Market
Table 70. Inhalable Drugs Market Restraints in Global Market
Table 71. Inhalable Drugs Raw Materials
Table 72. Inhalable Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Inhalable Drugs Downstream
Table 74. Inhalable Drugs Downstream Clients in Global Market
Table 75. Inhalable Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Inhalable Drugs Segment by Type
Figure 2. Inhalable Drugs Segment by Application
Figure 3. Global Inhalable Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inhalable Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inhalable Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Inhalable Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Inhalable Drugs Revenue in 2021
Figure 9. By Type - Global Inhalable Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Inhalable Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Inhalable Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Inhalable Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Inhalable Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Inhalable Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Inhalable Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Inhalable Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Inhalable Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Inhalable Drugs Sales Market Share, 2017-2028
Figure 19. US Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Inhalable Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Inhalable Drugs Sales Market Share, 2017-2028
Figure 24. Germany Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Inhalable Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Inhalable Drugs Sales Market Share, 2017-2028
Figure 33. China Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Inhalable Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Inhalable Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Inhalable Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Inhalable Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Inhalable Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Inhalable Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Inhalable Drugs by Region, 2021 VS 2028
Figure 50. Inhalable Drugs Industry Value Chain
Figure 51. Marketing Channels